Antigenics Inc., of New York, added Margaret Eisen, Wadih Jordan and Mark Kessel to its board and named Jeff Clark chief financial officer...Corgentech Inc., of Palo Alto, Calif., appointed Jack Regan vice president for manufacturing

and expanded Howard Richman's responsibilities to include manufacturing activities as senior vice president of regulatory and operations...Connetics Corp., of Palo Alto, Calif., appointed Andrew Eckert to its board

Cellular Genomics Inc., of Branford, Conn., named Thomas Gerson chief financial officer and promoted Mark Velleca to vice president of research and preclinical development...Nanosys Inc., of Palo Alto, Calif., added Louis Brus as scientific adviser

GenVec Inc., of Gaithersburg, Md., appointed David Wright president and chief operating officer...Hybridon Inc., of Cambridge, Mass., elected William Reardon and Georges Marcel to its board...ISTA Pharmaceuticals Inc., of Irvine, Calif., appointed Richard Williams, Benjamin McGraw and Wayne Roe to its board

Corgentech Inc., of Palo Alto, Calif., appointed Lynn Seely vice president of clinical research...Tensor Biosciences, of Irvine, Calif., appointed Joseph Coyle, Richard Morris, Roger Nicoll and Samuel Deadwyler to its scientific advisory board

Corgentech Inc., of Palo Alto, Calif., appointed Lynn Seely vice president of clinical research...CV Therapeutics Inc., of Palo Alto, Calif., said Luiz Belardinelli, its vice president, drug research and pharmacological sciences, was named the first CV Therapeutics distinguished fellow of cardiovascular science

Incyte Genomics Inc., of Palo Alto, Calif., added Jason Rubin as executive vice president of corporate affairs...It also promoted Matthew Linnik to chief scientific officer and executive vice president of research and William Welch to vice president of sales and marketing

Nanosys Inc., of Palo Alto, Calif., added Wallace Parce as chief technology officer and vice president of research

Corgentech Inc., of Palo Alto, Calif., appointed James Huang vice president of marketing and business development

Affymax Inc., of Palo Alto, Calif., appointed Tracy Dunn vice president of intellectual property...Laurence McCarthy, former president and CEO, will become chairman and chief technology officer

Genencor International Inc., of Palo Alto, Calif., added Theresa Lee and Gregory Nelson to its board

Affymax Inc., of Palo Alto, Calif., appointed Daniel Levitt chief operating officer and head of research and development...and named John Prunty treasurer and assistant corporate secretary

Connetics Corp., of Palo Alto, Calif., appointed Charles Democko vice president, regulatory affairs...Also, Fred Kurland was named vice president and chief financial officer and Laurie Torres named vice president of human resources

Corgentech Inc., of Palo Alto, Calif., promoted Mauri Okamoto-Kearney to vice president of product development...Sutter Hill Ventures, of Palo Alto, Calif., added Jeffrey Bird to its firm in the health care industry investment area

Affymax Inc., of Palo Alto, Calif., appointed Helen Kim chief business officer...AnVil Inc., of Burlington, Mass., named Kurt Thearling director, engineering, and Natasha Markuzon informatics scientist

Genencor International Inc., of Palo Alto, Calif., formed a health care advisory board, consisting of Martin Rosenberg, Stephen Carter, Donald Ganem and Arthur Weiss

Affymax Inc., of Palo Alto, Calif., elected Scott Greer to its board...and Robert Tenerowicz to vice president, process development and clinical supplies

Corgentech Inc., of Palo Alto, Calif., promoted Leslie McEvoy to vice president of research...Inhibitex Inc., of Atlanta, appointed James Barrett and Douglas Eplett to its board

Genencor International Inc., of Palo Alto, Calif., named Mark Goldsmith vice president, molecular medicine and strategy, and Kim Graham vice president, drug development...Incyte Genomics Inc., of Palo Alto, Calif., appointed Brian Metcalf executive vice president and chief drug discovery scientist